Colgate-Palmolive Co (CL) Stock News

EXCLUSIVE: Iran's Revolutionary Guards set up covert Iraqi cells to attack Gulf neighbors, sources say  Reuters

A class action lawsuit has been filed against Veritone, Inc. for allegedly making false statements and failing to disclose inaccurate revenue recording, misclassified costs, overstated financial metrics, and deficient internal controls. Investors who purchased Veritone securities between October 14, 2025 and April 14, 2026 have until July 20, 2026 to apply as lead plaintiff.

A class action lawsuit has been filed against Calix, Inc. in the U.S. District Court for the Northern District of California. The complaint alleges that Calix made materially false and misleading statements regarding the company's margins and business prospects during the Class Period (January 28, 2026 - April 21, 2026). Specifically, defendants allegedly failed to disclose that first quarter margins benefited from advanced memory component purchasing, that supplies were dwindling, and that the company faced negative margin pressure from rising memory component costs. Investors have until July 27, 2026 to apply to be appointed as lead plaintiff.

Euro Tech Holdings (NASDAQ: CLWT) shares surged 12.17% after hours to $1.76, extending a 30.83% intraday gain following an announcement of a strategic partnership with Norway-based Sea Clean AS. The partnership will launch a next-generation hybrid Ballast Water Port Reception & Treatment Facility in Norway, with the mobile facility scheduled for deployment in early July. The company plans to showcase the system at SMM 2026 in Hamburg, Germany in September, signaling European expansion opportunities.

The article compares two banking ETFs: Fidelity's FNCL offers broader financial sector exposure with lower costs (0.08% expense ratio) and greater stability, while iShares' IAT focuses on regional banks with higher dividend yields (2.82%) but greater volatility. FNCL is recommended for conservative investors seeking diversification, while IAT suits income-focused investors willing to accept higher risk.

Scilex Holding Company shares surged 18.79% after announcing that its Dream Bowl I Meme Coin tokens will begin trading on Biconomy Exchange as early as June 23. The listing is expected to improve liquidity and enable broader distribution for eligible token holders. Scilex is a biotech company focused on non-opioid pain management products.

A class action lawsuit has been filed against Zillow Group for allegedly making false and misleading statements regarding its agreement with Redfin Corporation. The lawsuit claims Zillow mischaracterized the transaction as a 'partnership' when it was actually an acquisition, and failed to disclose heightened regulatory and antitrust risks. Investors who purchased Zillow stock between February 11, 2025 and May 7, 2026 may be eligible to participate.

Defiance ETFs announced that the Cboe BZX Exchange has authorized the resumption of trading for the Defiance Daily 2X Space ETF (SPCL) on June 17, 2026, following a temporary trading halt on June 12. The fund's underlying portfolio assets remained secure throughout the suspension. SPCL is a leveraged ETF designed for experienced investors seeking 2X daily exposure to space sector securities, with significant risks including concentration in SpaceX and derivative instrument limitations.

Defiance ETFs announced that Cboe BZX Exchange has approved the resumption of trading for the Defiance Daily 2X Space ETF (SPCL) after a temporary trading suspension that began on June 12, 2026. The fund seeks 2X daily leveraged exposure to space companies, particularly SpaceX, and carries significant risks including concentration risk, daily rebalancing effects, and volatility associated with newly listed companies.

Defiance ETFs announced that Cboe BZX Exchange has approved the resumption of trading for the Defiance Daily 2X Space ETF (SPCL) after a suspension on June 12, 2026. The exchange exercised its discretionary authority to halt and subsequently resume trading. The fund's portfolio assets remained secure during the suspension. SPCL is a leveraged ETF designed for short-term trading with 2X daily exposure to space sector securities, including potential SpaceX exposure.

Defiance ETFs announced that the Cboe BZX Exchange has approved the resumption of trading for the Defiance Daily 2X Space ETF (SPCL) after a temporary trading halt on June 12, 2026. The fund, which seeks 2x daily leverage exposure to space-related companies including SpaceX, can now resume normal market trading. The halt was exercised by the exchange under its regulatory authority, and the underlying portfolio assets remained secure during the suspension.

Calidi Biotherapeutics announced it received positive pre-IND feedback from the FDA for its lead candidate CLD-401, an oncolytic virus with IL-15 superagonist delivery. The company plans to submit an IND application by end of 2026 and initiate first-in-human clinical trials in early 2027. The FDA alignment on CMC, non-clinical programs, and clinical study design represents a significant regulatory milestone for the company's RedTail platform.

Comstock Resources sold a 27% non-controlling equity interest in its midstream subsidiary Pinnacle Gas Services to Sixth Street for $600 million, valuing Pinnacle at $2.2 billion enterprise value. Comstock retained 73% controlling interest and used proceeds to eliminate all Pinnacle debt and preferred equity while reducing annual fixed charges by approximately $40 million. The transaction strengthens Comstock's balance sheet and validates the value of its Western Haynesville acreage.

Following SpaceX's IPO, traders are expanding their 'all things Elon' investment strategy beyond Tesla to include the space company. Direxion has launched a leveraged 2X bull ETF (LOFF) for SpaceX, mirroring its successful Tesla ETF (TSLL) strategy. The IPO is attracting unprecedented retail and institutional investor interest, suggesting strong demand for Musk-linked investments.

Direxion CEO Douglas Yones warns that SpaceX's valuation is primarily sentiment-driven rather than fundamentally justified. While the company benefits from being the largest IPO ever, Elon Musk's leadership, and AI investment hype, Yones cautions that if investors begin demanding cash flows commensurate with the valuation, SpaceX could face weakness. The company's fundamentals may not support its current lofty valuation in the long term.

Defiance ETFs CIO Sylvia Jablonski argues that investors are undervaluing SpaceX by viewing it solely as a rocket company rather than a multi-platform infrastructure business spanning launch, communications, defense, AI connectivity, and data services. She highlights Starlink's massive addressable market and positions SpaceX as an AI infrastructure play. Defiance launched a 2X leveraged SpaceX ETF (SPCU) to provide amplified daily exposure to the stock.

Defiance ETFs announced that trading of its Defiance Daily 2X Space ETF (SPCL) was temporarily halted on the Cboe BZX Exchange on June 14, 2026, at 10:45 AM ET due to significant market volatility surrounding SpaceX's IPO and the start of trading of SpaceX Class A common stock (NASDAQ: SPCX). Trading is expected to resume on June 15, 2026. The fund's underlying assets remain secure during the halt.

Cboe BZX Exchange temporarily halted trading of the Defiance Daily 2X Space ETF (SPCL) at 10:45 AM EDT on June 14, 2026, due to significant market volatility following SpaceX's IPO. Trading is expected to resume by Monday, June 15, 2026. The fund seeks to provide 2X daily leveraged exposure to SpaceX Class A common stock and other space company securities.

Defiance ETFs' Defiance Daily 2X Space ETF (SPCL) trading was temporarily halted on Cboe BZX Exchange on June 14, 2026, following significant market volatility after SpaceX completed its IPO and began trading on Nasdaq under ticker SPCX. The fund, which provides 2x daily leveraged exposure to SpaceX stock, experienced trading suspension due to extreme price fluctuations. Trading is expected to resume on June 15, 2026. The fund carries substantial risks including concentration risk, leverage risk, and volatility amplification.

Defiance ETFs announced a temporary trading halt of its Defiance Daily 2X Space ETF (SPCL) on the Cboe BZX exchange starting June 14, 2026 at 10:45 AM ET, citing extreme market volatility following SpaceX's IPO completion and Nasdaq listing of SpaceX Class A shares (ticker: SPCX). Trading is expected to resume on June 15, 2026. The fund's underlying assets remain secure during the halt.

Defiance ETFs' Defiance Daily 2X Space ETF (SPCL) experienced a temporary trading halt on Cboe BZX Exchange on June 14, 2026, following SpaceX's IPO and the start of trading of SpaceX Class A shares on Nasdaq. The halt was triggered by significant price volatility in SpaceX stock on its first trading day. The fund, which provides 2x daily leveraged exposure to space companies including SpaceX, is expected to resume trading on June 15, 2026 or later. The fund's portfolio assets remain secure during the trading suspension.

Genmab announced positive Phase 2 and Phase 1b/2 trial results for epcoritamab in elderly DLBCL patients. The monotherapy arm (EPCORE DLBCL-3) showed 67% overall response rate and 58% complete response rate, while the combination with R-mini-CHOP (EPCORE NHL-2) demonstrated 93% overall response rate and 86% complete response rate with durable remissions and sustained MRD negativity.

Defiance ETFs announced the launch of Defiance Daily 2X Space ETF (SPCL), which provides 2x daily leveraged exposure to SpaceX (SPCX) on its IPO day. SpaceX priced its IPO at $135 per share, valuing the company at approximately $1.77 trillion, making it the largest U.S. IPO by first-day market capitalization. The ETF is designed for active traders seeking short-term leveraged positions but carries significant risks including daily compounding effects, concentration risk, and potential total loss of principal.

Defiance ETFs announced the launch of Defiance Daily 2X Space ETF (SPCL), the first U.S. ETF offering 2X daily leveraged exposure to SpaceX Class A shares on its IPO day. SpaceX priced its IPO at $135 per share, achieving a valuation of approximately $1.77 trillion, marking the largest IPO in U.S. history by market value on listing day. The ETF is designed for active traders and carries significant risks including daily rebalancing, concentration risk, and potential total loss of principal.

SpaceX began trading on Nasdaq on June 13, 2026, under ticker SPCX at an IPO price of $135 per share, achieving a valuation of approximately $1.77 trillion—reportedly the largest U.S. IPO by first-day market value. Defiance ETFs launched the Defiance Daily 2X Space ETF (SPCL), the first and only U.S. ETF offering 2X daily leveraged exposure to SpaceX Class A common stock on the IPO day.

Defiance ETFs announced the launch of Defiance Daily 2X Space ETF (SPCL) on Cboe, becoming the first and only U.S. ETF offering 2X daily leveraged exposure to SpaceX Class A shares on the company's IPO day. SpaceX priced its IPO at $135 per share, valuing the company at approximately $1.77 trillion, marking the largest IPO by opening day market cap in U.S. history. However, the article extensively warns of significant risks including leverage complexity, concentration risk, derivatives exposure, and SpaceX-specific risks related to Elon Musk's control and unproven technologies.

Defiance ETFs announced the launch of the Defiance Daily 2X Space ETF (SPCL), which provides 2x daily leveraged exposure to SpaceX Class A common stock on its IPO day. SpaceX priced its IPO at $135 per share, valuing the company at approximately $1.77 trillion, marking the largest IPO in U.S. history by market capitalization. The ETF is designed for active traders and carries significant risks including potential total loss of principal within a single trading day.

Cboe BZX Exchange temporarily halted trading of the Defiance Daily 2X Space ETF (SPCL) at 10:45 A.M. EDT on June 12, 2026, due to significant market volatility surrounding SpaceX's initial public offering and the commencement of trading in SpaceX Class A common stock (SPCX) on Nasdaq. Trading is expected to resume no earlier than Monday, June 15, 2026. The fund's underlying portfolio assets remain secure during the halt.

WisdomTree's Christopher Gannatti argues that SpaceX's IPO presents a unique valuation challenge because the company operates across multiple business segments—rocket launches, satellite broadband (Starlink), and AI infrastructure—that don't fit neatly into existing categories. This complexity will likely create persistent disagreement among analysts about fair value, potentially generating both volatility and investment opportunities.

SpaceX may be strategically choosing not to prioritize profitability, instead reinvesting heavily in Starship and AI infrastructure to drive long-term growth. This mirrors Amazon's historical approach of accepting near-term losses for future opportunities. Experts argue the company could be profitable today if it reduced capital expenditures, but investors are willing to accept this strategy based on the company's ambitious vision.